Myriad Genetics Stock Price on December 12, 2024
| MYGN Stock | USD 13.65 0.29 2.17% |
Below is the normalized historical share price chart for Myriad Genetics extending back to October 06, 1995. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Myriad Genetics stands at 13.65, as last reported on the 24th of December, with the highest price reaching 13.67 and the lowest price hitting 13.18 during the day.
If you're considering investing in Myriad Stock, it is important to understand the factors that can impact its price. Myriad Genetics has Sharpe Ratio of -0.29, which conveys that the firm had a -0.29% return per unit of risk over the last 3 months. Myriad Genetics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Myriad Genetics' Mean Deviation of 2.17, standard deviation of 3.3, and Risk Adjusted Performance of (0.23) to check out the risk estimate we provide.
Myriad Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of October 1995 | 200 Day MA 22.7053 | 50 Day MA 17.8566 | Beta 1.937 |
Myriad |
Sharpe Ratio = -0.286
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MYGN |
Estimated Market Risk
| 3.37 actual daily | 30 70% of assets are more volatile |
Expected Return
| -0.96 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.29 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Myriad Genetics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Myriad Genetics by adding Myriad Genetics to a well-diversified portfolio.
Price Book 1.6622 | Enterprise Value Ebitda (23.47) | Price Sales 1.4767 | Shares Float 83.5 M | Wall Street Target Price 22.5333 |
Related Headline
Fate Therapeutics Headline on 12th of December 2024
Disposition of 6022 shares by Redmile Group, Llc of Fate The... by finance.yahoo.com
Filed transaction by Fate Therapeutics Director, 10 Percent Owner: . Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Myriad Genetics Valuation on December 12, 2024
It is possible to determine the worth of Myriad Genetics on a given historical date. On December 12, 2024 Myriad was worth 14.49 at the beginning of the trading date compared to the closed value of 14.5. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Myriad Genetics stock. Still, in general, we apply an absolute valuation method to find Myriad Genetics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Myriad Genetics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Myriad Genetics' related companies.
| Open | High | Low | Close | Volume | |
| 15.32 | 15.37 | 14.50 | 14.51 | 965,013 | |
12/12/2024 | 14.49 | 15.44 | 14.20 | 14.50 | 2,683,928 |
| 14.34 | 14.74 | 13.92 | 14.43 | 1,148,550 |
| Backtest Myriad Genetics | | | Myriad Genetics History | | | Myriad Genetics Valuation | Previous | Next |
Myriad Genetics Trading Date Momentum on December 12, 2024
| On December 13 2024 Myriad Genetics was traded for 14.43 at the closing time. The top price for the day was 14.74 and the lowest listed price was 13.92 . The trading volume for the day was 1.1 M. The trading history from December 13, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.48% . The trading delta at closing time against the current closing price is 7.72% . |
Myriad Genetics Fundamentals Correlations and Trends
By evaluating Myriad Genetics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Myriad Genetics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Myriad financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Myriad Genetics Stock history
Myriad Genetics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Myriad is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Myriad Genetics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Myriad Genetics stock prices may prove useful in developing a viable investing in Myriad Genetics
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company was founded in 1991 and is headquartered in Salt Lake City, Utah. Myriad Genetics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 2400 people.
Myriad Genetics Quarterly Net Working Capital |
|
Myriad Genetics Stock Technical Analysis
Myriad Genetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Myriad Genetics Period Price Range
Low | December 24, 2024
| High |
0.00 | 0.00 |
Myriad Genetics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Myriad Genetics December 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Myriad Genetics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Myriad Genetics shares will generate the highest return on investment. By undertsting and applying Myriad Genetics stock market strength indicators, traders can identify Myriad Genetics entry and exit signals to maximize returns
Myriad Genetics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Myriad Genetics' price direction in advance. Along with the technical and fundamental analysis of Myriad Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Myriad to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.23) | |||
| Jensen Alpha | (1.04) | |||
| Total Risk Alpha | (1.11) | |||
| Treynor Ratio | (1.21) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myriad Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Myriad Stock, please use our How to Invest in Myriad Genetics guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myriad Genetics. If investors know Myriad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myriad Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.28) | Revenue Per Share 9.205 | Quarterly Revenue Growth 0.112 | Return On Assets (0.05) | Return On Equity (0.16) |
The market value of Myriad Genetics is measured differently than its book value, which is the value of Myriad that is recorded on the company's balance sheet. Investors also form their own opinion of Myriad Genetics' value that differs from its market value or its book value, called intrinsic value, which is Myriad Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myriad Genetics' market value can be influenced by many factors that don't directly affect Myriad Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myriad Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Myriad Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myriad Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.